CMPS

Compass Pathways Plc

NASDAQ: CMPS · HEALTHCARE · MEDICAL CARE FACILITIES

$9.37

-7.20% today

Updated 2026-06-05

Market cap

$1.78B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.14

Dividend yield

—

52W range

$2 – $15

Volume

4.5M

Market cap

$1.78B

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.14

Dividend yield

—

52W range

$2 – $15

Volume

4.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

-10.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$22.20

+136.93%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

3 Strong Buy11 Buy1 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.01x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Altman Z -10.28 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-47.94M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-91.50M	$-118.46M	$-155.12M	$-287.86M	$91.05M
EPS	—	—	—	—	$-3.14
Free cash flow	$-106.05M	$-97.44M	$-119.19M	$-157.24M	$-47.94M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-26	NATH, KABIR	Buy	367,815	—
2026-03-26	NATH, KABIR	Buy	175,000	—
2026-03-26	LOXAM, TERI	Buy	157,635	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CMPS	$1.78B	23	4.3	3.0	5.0	6.5	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Compass Pathways Plc trades at $9.37. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of -10.28, it sits in the distress.

Frequently asked questions

What is Compass Pathways Plc's stock price?

Compass Pathways Plc (CMPS) trades at $9.37.

Is Compass Pathways Plc overvalued?

Compass Pathways Plc carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Compass Pathways Plc (CMPS)?

The 12-month analyst consensus target is $22.20, about 136.9% above the current $9.37. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Compass Pathways Plc's Altman Z-Score is -10.28, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryMEDICAL CARE FACILITIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

compasspathways.com

Quick metrics

P/S ratio—

ROE-54.78%

Beta2.41

50D MA$8.72

200D MA$6.79

Shares out0.13B

Float0.10B

Short ratio—

Avg volume4.5M

Performance

1 week+64.52%

1 month+74.86%

3 months+29.41%

YTD+37.10%

1 year—

3 years—

5 years—

Compare

CMPS vs LLY →CMPS vs JNJ →CMPS vs ABBV →Stock screener →